CNN to Feature IMF's iStopMM® Project

CNN Features IMF's iStopMM Project in Report on Innovative Research in Iceland

On Saturday, May 6th, 2017, at 11:30 AM PT / 2:30 PM ET, CNN US will broadcast an episode of “Vital Signs,” which features CNN Chief Medical Correspondent Dr. Sanjay Gupta reporting from Iceland. Dr. Gupta interviewed International Myeloma Foundation Chairman Dr. Brian Durie and Principal Investigator Dr. Sigurdur Kristinsson about the Black Swan Research Initiative® iStopMM® project. To learn about the iStopMM project and this CNN broadcast, read Dr. Durie’s blog, and explore the IMF’s Black Swan Research Initiative.

European Commission Approves Darzalex (daratumumab) Combination Therapy

On April 28th, 2017, the European Commission announced that it has granted approval to Darzalex® (daratumumab) for use in combination with Revlimid® (lenalidomide) and dexamethasone, or Velcade® (bortezomib) and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. The European Commission’s decision was based on data from the phase III POLLUX study, and the phase III CASTOR study.

  

 

An Update on NIH Funding

On Sunday evening, Congressional leaders reached a government funding compromise which will carry through the end of September. We are happy to report this compromise includes $2 billion in new NIH funds, despite fears the agency would receive cuts. This additional funding will greatly help Cancer Moonshot efforts.

 

Updated 2017 IMF Educational Publications Available to Download or Order

The IMF publications Understanding Darzalex (daratumumab)Understanding Empliciti (elotuzumab), and Understanding Dexamethasone and Other Steroids have been updated for 2017.

  

 

Runners and Walkers in Cincinnati Raise Funds for the IMF

Miracles happen when pigs fly! The 2017 Flying Pig fundraiser will take place on Saturday, May 6th and Sunday, May 7th in Cincinnati, Ohio. In addition to full and half-marathoners, myeloma patients with family and friends will be walking/running in a 5K race to raise money for the IMF’s myeloma education and research programs.

 

 

Can myeloma cells be detected in the blood instead of the bone marrow?

In this week’s video, Dr. Brian Durie sheds light on advances in testing for myeloma cells in the blood.

BOTTOM LINE:
Using blood instead of bone marrow to test for myeloma cells may become feasible in the future.

 


We Would Like to Thank Our Sponsors: Takeda, Celgene, Amgen, and Bristol-Myers Squibb